Table 2.
Patient Concern | High-Penetrance Genes | Moderate-Penetrance Genes | Limited Data/Low-Risk Genes |
---|---|---|---|
Cancer risk | High cancer risks, likely explains cancer in family | Moderate cancer risks, may explain cancer in family | Unknown cancer risk, may explain cancer in the family |
Medical-management options | Many options, which may include increased screening, preventative surgery, and chemopreventiona | Options generally involve increased screening beginning at younger ages | Established guidelines not yet available; clinician will make recommendations based on current data and the patient’s personal and family medical history |
Implications for family members | Recommend testing to all blood relatives. Negative results are considered “true negative” results | Family members should consider genetic testing; family members with negative results may still have increased risk of cancer based on the family history | Unknown implications for family members |
aIt is important to discuss limitations in cancer screening and prevention. It is not possible to effectively screen for all cancer risks conferred by a high-penetrance gene. For example, TP53 mutations cause risk of many cancer types, and screening options are of unknown efficacy.